Quinze-Vingts National Ophthalmology Hospital, INSERM-DGOS CIC 1423, IHU Foresight, Paris, France; Sorbonne Université, INSERM, CNRS, Institut de La Vision, Paris, France; Department of Ophthalmology, Ambroise Paré Hospital, APHP, Université de Versailles Saint-Quentin en Yvelines, Boulogne-Billancourt, France.
Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark; Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet-Glostrup, Glostrup, Denmark.
Prog Retin Eye Res. 2021 Jul;83:100916. doi: 10.1016/j.preteyeres.2020.100916. Epub 2020 Oct 17.
The pathophysiology of glaucoma is complex, multifactorial and not completely understood. Elevated intraocular pressure (IOP) and/or impaired retinal blood flow may cause initial optic nerve damage. In addition, age-related oxidative stress in the retina concurrently with chronic mechanical and vascular stress is crucial for the initiation of retinal neurodegeneration. Oxidative stress is closely related to cell senescence, mitochondrial dysfunction, excitotoxicity, and neuroinflammation, which are involved in glaucoma progression. Accumulating evidence from animal glaucoma models and from human ocular samples suggests a dysfunction of the para-inflammation in the retinal ganglion cell layer and the optic nerve head. Moreover, quite similar mechanisms in the anterior chamber could explain the trabecular meshwork dysfunction and the elevated IOP in primary open-angle glaucoma. On the other hand, ocular surface disease due to topical interventions is the most prominent and visible consequence of inflammation in glaucoma, with a negative impact on filtering surgery failure, topical treatment efficacy, and possibly on inflammation in the anterior segment. Consequently, glaucoma appears as an outstanding eye disease where inflammatory changes may be present to various extents and consequences along the eye structure, from the ocular surface to the posterior segment, and the visual pathway. Here we reviewed the inflammatory processes in all ocular structures in glaucoma from the back to the front of the eye and beyond. Our approach was to explain how para-inflammation is necessary to maintain homoeostasis, and to describe abnormal inflammatory findings observed in glaucomatous patients or in animal glaucoma models, supporting the hypothesis of a dysregulation of the inflammatory balance toward a pro-inflammatory phenotype. Possible anti-inflammatory therapeutic approaches in glaucoma are also discussed.
青光眼的病理生理学复杂、多因素且尚未完全阐明。眼内压升高(IOP)和/或视网膜血流受损可能导致视神经的初始损伤。此外,与慢性机械和血管应激同时发生的视网膜年龄相关性氧化应激对视神经退行性变的发生至关重要。氧化应激与细胞衰老、线粒体功能障碍、兴奋性毒性和神经炎症密切相关,这些都参与了青光眼的进展。动物青光眼模型和人眼样本的大量证据表明,视网膜神经节细胞层和视神经头的副炎症功能障碍。此外,前房中相当类似的机制可以解释原发性开角型青光眼小梁网功能障碍和眼压升高。另一方面,由于局部干预引起的眼表疾病是青光眼炎症最突出和可见的后果,对滤过性手术失败、局部治疗效果以及前段炎症都有负面影响。因此,青光眼是一种突出的眼病,炎症变化可能在眼结构的各个方面和程度上存在,从眼表面到后段和视觉通路。在这里,我们回顾了青光眼所有眼结构从后到前以及超越眼结构的炎症过程。我们的方法是解释副炎症如何维持内稳态,并描述在青光眼患者或动物青光眼模型中观察到的异常炎症发现,支持炎症平衡失调向促炎表型的假说。还讨论了青光眼的可能抗炎治疗方法。